Development of a Clinical and Biological Database in Peritoneal Carcinosis (BCB CARCINOSE)
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: biological collection, Tissues collections.
- Who it may be relevant to
- Registry conditions: Cancer, Peritoneal Carcinosis. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- France
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Development of a Clinical and Biological Database Monocentric and Prospective in Peritoneal Carcinosis
Overview
The creation of a prospective clinical-biological base dedicated to peritoneal carcinosis must therefore be able to serve as a support for this essential search for transfer.
Detailed description
The main objective is to improve the knowledge of carcinosis mechanisms to develop a specific treatment.
That's why this blood collection and tissue collection is very important for the future, these collection will be permitted to the scientists to develop a research specially for carcinosis.
Interventions
- Biological biological collection
Blood samples collected before any treatment (if chemotherapy for example), at every surgery, one month after surgery, at progression - Other Tissues collections
Tumours and not tumours tissues will be collected before any treatment (if chemotherapy for example), at every surgery, one month after surgery, at progression
Primary outcome measures
- Proportion of patients who gave their consent to participate in the study [Time frame: Until the study completion: 4 years]
Eligibility criteria
Inclusion criteria
- Patient over the age of 18;
- Patient managed for peritoneal carcinosis : digestives origins (pancreatic, gastroesophageal junction, colorectal, bowel) or peritoneum cancer
- Patient eligible for a peritoneal carcinosis treatment : at least one (or more) surgery (s) ;chemotherapy or any treatment for this disease
- Patient agree will all study procedure : biological samples \& tissues samples
- Patient giving informed consent
Exclusion criteria
- Patient not affiliated to Social Protection system
- Patient unable to understand or comply with study instructions or requirements for psychological, family, social or geographical reasons
- The level of French is insufficient to consent to the study and to response to the questionnaires
- Patient under guardianship
- Pregnancy ou breast-feeding women
- Patient treated in case of an emergency
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Other
Study locations
France · 1 center
- Institut du cancer de Montpellier ICM — Montpellier
Identifiers
NCT: NCT04221464 · PROICM 2019-01 BCA